Characterization of antigenic peptides presented by HLA-B44 molecules on tumor cells expressing the gene MAGE-3

International Journal of Cancer

Volumn 68, Issue 5, 1996, Pages 622-628

  Fleischhauer, Katharina ^a,f   Fruci, Doriana ^a,b,c   Van Endert, Peter ^a,b,c,d   Herman, Jean ^a,b,c,d,e   Tanzarella, Silvia ^a,b,c,d,e   Wallny, Hans J ^a,b,c,d,e   Coulie, Pierre ^a,b,c,d,e   Bordignon, Claudio ^a,b,c,d,e   Traversari, Catia ^a,b,c,d  

^a SAN RAFFAELE HOSPITAL   (Italy)

^b CNR   (Italy)

^c INSERM   (France)

^d LUDWIG INSTITUTE FOR CANCER RESEARCH   (Belgium)

^e BASEL INSTITUTE FOR IMMUNOLOGY   (Switzerland)

^f BIOTEST AG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B ANTIGEN; SYNTHETIC PEPTIDE; TUMOR ANTIGEN;

AMINO ACID SEQUENCE; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL; TUMOR IMMUNITY;

AMINO ACID SEQUENCE; ANTIGEN PRESENTATION; ANTIGENS, NEOPLASM; GENE EXPRESSION REGULATION, NEOPLASTIC; HLA-B ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; NEOPLASM PROTEINS; PEPTIDES; TUMOR CELLS, CULTURED;

EID: 0029852657     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961127)68:5<622::AID-IJC12>3.0.CO;2-3     Document Type: Article

References (20)

1. BOEL, P., WILDMANN, C., SENSI, M.L., BRASSEUR, R., RENAULD, J.C., COULIE, P., BOON, T. and VAN DER BRUGGEN, P., BACE: a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity, 2, 167-175 (1995).
2. BOON, T., CEROTTINI, J.C., VAN DEN EYNDE, B., VAN DER BRUGGEN, P. and VAN PEL, A., Tumor antigens recognized by T lymphocytes. Ann. Rev. Imimmol, 12, 337-365 (1994).
3. CELIS, E., TSAI, V., CRIMI, C., DEMARS, R., WENTWORTH, P.A., CHESNUT, R.W., GREY, H.M., SETTE, A. and SERRA, H.M., Induction of anti-tumor cytotoxic T lymphocytes in normal humans using primary cultures and synthetic peptide epitopes. Proc. not. Acad. Sei. (Wash.), 91, 2105-2109(1994).
4. Di BIRINO, M., PARKER, K.C., MARGULIES, D.H., SHILOACH, J., TURNER, R.V., BIDDISON, W.E. and COLIGAN, J.E., Identification of the peptide binding motif for HLA-B44, one of the most common HLA-B alleles in the Caucasian population. Biochemistry, 34, 10130-10138(1995).
5. FLEISCHHAUER, K., AVILA, D., VILBOIS, F., TRAVERSARI, C, BORDIGNON, C. and WALLNY, H.J., Characterization of natural peptide ligands for HLA-B*4402 and -B*4403: implications for peptide involvement in allorecognition of a single amino acid change in the HLA-B44 heavy chain. Tissue Antigens, 44, 311-317(1994).
6. FLEISCHHAUER, K., KERNAN, N.A., DUPONT, B. and YANG, S.Y., The two major subtypes of HLA-B44 differ for a single amino acid at codon 156. Tissue Antigens, 37, 133-137 (1991).
7. FLEISCHHAUER, K., ZINO, E., BORDIGNON, C. and BENAZZI, E., Complete generic and extensive fine-specificity typing of the HLA-B locus by the PCR-SSOP method. Tissue Antisens, 46, 281-292 (1995).
8. Λ subtype (B*2705) analyzed by the use of polyalanine model peptides. Hum. Immunol., 41, 34-41 (1994).
9. GAUGLER, B., VAN DEN EYNDE, B., VAN DER BRUGGEN, P., ROMERO, P., GAFORIO, J.J., DEPLAEN, E., LETHÉ, B., BRASSEUR, F. and BOON, T., Human gene MAGE-3 codes for an antigen recognized on melanoma cell by autologous cytolytic lymphocytes. J. exp. Med., 179, 921-930 (1994).
10. HERMAN, J., VAN DER BRUGGEN, P., LUESCHER, I.F., MANDRUZZATO, S., ROMERO, P., THONNARD, J., FLEISCHHAUER, K., BOON, T. and COULIE, P.O., A peptide encoded by human gene MAGE-3 induces cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Immunogenetics 43, 377-383 (1996).
11. IMANISHI, T., AKAZA, T., KIMURA, A., TOKUNAOA, K. and GOJOBORI, T., Allele and haplotype frequencies for HLA and complement loci in various ethnic groups. In: K. Tsuji, M. Aizawa and T. Sasazuki, (eds.), HLA 1991. Proceedings of Xlth International Histocompatibility Workshop and Conference, Ko; 1., pp. 1065-1170, Oxford University Press, Oxford (1992).
12. RAMMENSEE, H.G., FRIEDE, T. and STEVANOVIC, S., MHC ligands and peptide motifs: first listing. Immunogenetics, 41, 178-228 (1995).
13. ROCK, K.L., GRAMM, C, ROTHSTEIN, L., CLARK, K., STEIN, R., DICK, L., HWANG, D. and GOLDBERG, A.L., Inhibitors of the proteasome block the degradation of most cell proteins and the generation of peptides presented on MHC class I molecules. Cell, 78, 761-771 (1994).
14. SAFER, M.A., BJORKMAN, P.A. and WILEY, D.C., Refined structure of the human histocompatibility antigen HLA-A2 at 2.6A resolution. J. mol. Biol., 219, 277-319 (1991).
15. SETTE, A. and 16 OTHERS, The relationship between class I binding affinity and immunogenicity of potential cytotoxic T cell epitopes. J. Immunol, 153, 5586-5592 (1994).
16. TUSSEY, L.G., ROWLAND-JONES, S., ZHENG, T.S., ANDROLEWICZ, M.A., CRESSWELL, P., FREILINGER, J.A. and MCMICHAEL, A.J., Different MHC class I alleles compete for presentation of overlapping viral epitopes. Immunity, 3, 65-77 (1995).
17. VAN DEN EYNDE, B., PEETERS, O., DE BACKER, O., GAUGLER, B., LUCAS, S. and BOON, T., A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J, exp. Med., 82, 689-698 (1995).
18. VAN DER BRUGGEN, P., BASTIN, J., GAJEWSKI, T., COULIE, P., BOEL, P., DE SMET, C., TRAVERSARI, C., TOWNSEND, A. and BOON, T., A peptide encoded by human gene MAGE-3 and presented by HLA-A2 induced cytolytic T lymphocytes that recognize tumor cells expressing MAGE-3. Europ.J. Immunol., 12, 3038-3043 (1994a).
19. VAN DER BRUGGEN, P., SZIKFARA, J.P., BOEL, P., WILDMANN, C., SOMVILLE, M., SENSI, M. and BOON, T., Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Europ. J. Immunol., 24, 2134-2140 (19946).
20. VAN ENDERT, P.M., RIGANELLI, D., GRECO, G., FLEISCHHAUER, K., SIDNEY, J., SETTE, A. and BACH, J.F., The peptide binding motif for the human transporter associated with antigen processing (TAP). J. exp. Med., 182, 1883-1895(1995).